Not yet recruiting
Group B streptococcus neonatal sepsis
Not yet recruitingStudy on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49
Registered drug
Study on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49
Registered drug
- Disease:Group B streptococcus neonatal sepsis
- Substances:GBS-NNGBS-NN2
Countries:
Belgium
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:GBS-NN
- Sponsor:Minervax ApS




